Macro Dashboard
| Indicator | Level | 5-Day Change | Signal |
|---|---|---|---|
| KOSPI | 6,615.0 | +3.5% | Bullish |
| KOSDAQ | 1,226.2 | +4.0% | Bullish |
| VIX | 18.96 | −2.8% | Stable |
| US 10Y | 4.31% | +0.06pp | Neutral |
| USD/KRW | 1,470 | +0.1% | Stable |
| Brent | $100.37 | −1.5% | Stable |
Regime Verdict — KR: Bull | US: Neutral. Breadth above 50-MA sits at 68.0% (KOSPI names), above 200-MA at 60.4%, with 211 names passing the full operating screener. The divergence between a KR Bull and US Neutral regime argues for selective Korea expansion rather than broad index chasing.
Market Wrap
Monday’s Korea session had a single character: broad, conviction-driven risk-on. KOSPI extended intraday gains to +2.51% by 14:20, with KOSDAQ touching +1.83%, both well above early-morning Neutral expectations. The catalyst was a coordinated dual-engine bid — foreign and institutional investors buying together — which is the cleanest breadth signal the market can produce.
Semiconductors and HBM were the session’s undisputed leadership. Intel’s overnight beat in the US, combined with Philadelphia Semiconductor Index strength, imported momentum directly into Korean chipmakers. SK Hynix (000660.KS) surged over +6%, dragging the broader semiconductor complex higher. The move reinforced the thesis that AI infrastructure demand is still accelerating and that Korea’s chip supply chain sits at the center of it.
Power equipment was the second pillar. The AI power infrastructure theme — data center buildout driving demand for high-capacity transformers and switchgear — continues to find incremental buyers. LS ELECTRIC emerged as a standout name in intraday screening, with RS percentile near 98.9, though the session closed at elevated levels after a sharp run.
Machinery and marine engines registered one of the sharpest single-day moves in recent memory. Hanwha Engine (082740.KS) surged +16.5% on 1Q26 operating profit of ₩51.4bn, a +15% beat to consensus, with LNGC slow-speed engine margins expanding from high-single-digit to mid-teen levels. SK Securities raised its target to ₩100,000 from ₩72,000. The five-day move stands at +63%, placing it firmly in momentum-overextension territory near-term.
Robotics added speculative acceleration, with names like Robotis (108490.KQ) printing +19% on physical-AI momentum. That cadence — high RS, high velocity, one-session pop — is typical of momentum clustering in a confirmed bull breadth environment.
The weak side was predictable for a risk-on day: telecom and defensives underperformed on opportunity cost, not company-specific newsflow. Pharma and biotech laggards also stayed quiet. Within secondary batteries, divergence persisted — names with direct AI or power exposure held ground; pure EV-cycle plays did not.
Flow read: The foreign + institutional joint buying that drove today’s session is the most reliable bullish signal in the KRX data. When both actor classes accumulate simultaneously on rising volume, breadth tends to expand further over the following 2–5 sessions. Watch whether this dual-flow pattern repeats Tuesday as the key regime confirmation.
Today’s Screener Spotlight: PEAD (Post-Earnings Announcement Drift)
Monday rotation — PEAD. This screener targets the academically well-documented anomaly where stocks with strong earnings surprises continue to drift in the direction of the surprise for 1–4 weeks post-announcement. The filter requires OP YoY ≥40%, revenue YoY ≥15%, and margin expansion ≥2pp for Tier A names, combined with price confirmation above the 50-day moving average and room to the 52-week high.
Screened as of 2026-04-27 16:20 KST. 92 total candidates: 38 Tier A (Strong Beat), 27 Tier B (Clear Beat), 27 Tier C (Mild Beat).
Tier A — Top 8 by Composite Score
| # | Ticker | Name | Close (₩) | OP YoY | Rev YoY | Δ Margin | ROE | RS% | Score |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 489790.KS | Hanwha Vision | 88,800 | +2,851% | +263% | +7.95pp | 5.4% | 73 | +3.72 |
| 2 | 046940.KQ | Woowon Development | 5,650 | +2,300% | +24% | +16.92pp | 36.8% | 78 | +2.46 |
| 3 | 005690.KS | Pharmicell | 18,930 | +630% | +76% | +22.90pp | 38.3% | 84 | +1.82 |
| 4 | 330730.KQ | Stonebridge Ventures | 6,690 | +297% | +80% | +28.89pp | 12.4% | 75 | +1.82 |
| 5 | 307930.KQ | CompanyK | 9,440 | +197% | +43% | +23.59pp | 9.3% | 78 | +1.44 |
| 6 | 006910.KQ | Bosung Powertech | 12,190 | +458% | +91% | +11.92pp | 20.3% | 97 | +1.24 |
| 7 | 100840.KS | SNT Energy | 57,500 | +401% | +106% | +10.81pp | 25.2% | 73 | +1.21 |
| 8 | 425420.KQ | TFI | 65,200 | +334% | +52% | +11.09pp | 19.3% | 95 | +0.90 |
Top 3 in Context
Hanwha Vision (489790.KS) — Korea’s dominant machine-vision and video-surveillance hardware manufacturer, increasingly exposed to AI-inference edge computing and smart factory automation. The OP YoY of +2,851% reflects a low base recovery combined with margin-accretive product mix shift toward AI-enabled cameras. At 4.2% below its 52-week high with a 20-day return of +17.3%, drift runway remains meaningful. RS at 73 is the weakest element of the profile — worth monitoring for institutional flow confirmation.
Woowon Development (046940.KQ) — Mid-cap civil engineering and construction specialist with outsized margin leverage to public infrastructure project cycles. The +16.92pp margin expansion is the largest absolute margin gain in the Tier A cohort, suggesting fixed-cost absorption on a revenue base that grew +24% YoY. The 52-week gap of just 3.6% means it is near highs — PEAD logic argues the drift continues as long as the fundamental catalyst (multi-year project backlog) remains undiscounted.
Pharmicell (005690.KS) — Cell therapy and stem-cell-based regenerative medicine company. The +630% OP YoY on +76% revenue growth and a +22.9pp margin jump signals a transition from R&D burn phase to commercial-scale profitability. Biotech earnings inflections in Korea tend to receive delayed institutional recognition; the 5-day return of −1.4% alongside a strong 20-day return of +20.7% suggests early consolidation rather than reversal — a textbook PEAD setup if the broader market stays constructive.
Disclaimer: For research and information purposes only. Not investment advice. Names cited are for analytical illustration; readers should perform their own due diligence and consult licensed advisors before any investment decision.